Answers are grounded in this paper and cite their sources.
divided into two main groups based on their mechanism of action, namely immunomodulatory drugs like interferon and antiviral drugs, including lamivudine, adefovir, entecavir, tenofovir and telbivudine. 2 These drugs have a limited efficacy, rarely produce a sustained response and their prolonged use is associated to important adverse events. The use of vaccine formulations as immunotherapeutic strategies in the treatment of CHB constitutes an attractive approach. This review focuses on the use of hepatitis B surface antigen (HBsAg)-based vaccine formulations on CHB treatment and discuss the general conclusions coming from these studies and the potentialities of using HBsAg antigens in the future developments.
No takes yet. Share an insight, caveat, or question.
Lobaina et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: